|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-11-10
|
|
pubmed:abstractText |
Metastatic renal cell carcinoma is one of the few tumors for which a clear benefit of immunotherapy has been demonstrated. The aim of this study was to evaluate the long-term survival of patients with metastatic renal cell carcinoma, along with response rate and other prognostic and predictive factors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
pubmed-author:BalestreriLucaL,
pubmed-author:BerrettaMassimilianoM,
pubmed-author:BuonadonnaAngelaA,
pubmed-author:CrivellariDianaD,
pubmed-author:De CiccoMarcelloM,
pubmed-author:FreschiAndreaA,
pubmed-author:GalligioniEnzoE,
pubmed-author:LibraMassimoM,
pubmed-author:MerloAlbertoA,
pubmed-author:SorioRobertoR,
pubmed-author:StefanovskiPetarP,
pubmed-author:TalaminiRenatoR,
pubmed-author:VolpeRacheleR
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
400-4
|
|
pubmed:dateRevised |
2008-12-12
|
|
pubmed:meshHeading |
pubmed-meshheading:14606643-Aged,
pubmed-meshheading:14606643-Analysis of Variance,
pubmed-meshheading:14606643-Antineoplastic Agents,
pubmed-meshheading:14606643-Carcinoma, Renal Cell,
pubmed-meshheading:14606643-Female,
pubmed-meshheading:14606643-Follow-Up Studies,
pubmed-meshheading:14606643-Humans,
pubmed-meshheading:14606643-Infusions, Intravenous,
pubmed-meshheading:14606643-Interleukin-2,
pubmed-meshheading:14606643-Italy,
pubmed-meshheading:14606643-Kidney Neoplasms,
pubmed-meshheading:14606643-Male,
pubmed-meshheading:14606643-Middle Aged,
pubmed-meshheading:14606643-Multivariate Analysis,
pubmed-meshheading:14606643-Predictive Value of Tests,
pubmed-meshheading:14606643-Prognosis,
pubmed-meshheading:14606643-Recombinant Proteins,
pubmed-meshheading:14606643-Risk Factors,
pubmed-meshheading:14606643-Survival Analysis
|
|
pubmed:articleTitle |
Long-term survival in patients with metastatic renal cell carcinoma treated with continuous intravenous infusion of recombinant interleukin-2: the experience of a single institution.
|
|
pubmed:affiliation |
Division of Medical Oncology, Centro di Riferimento Oncologico, IRCCS, Aviano, PN, Italy.
|
|
pubmed:publicationType |
Journal Article
|
